pancreatic cancer

9 January 2026

The four milestones in cancer research in 2025, according to the AECC

One of these milestones belongs to the research led by our researcher Patricia Sancho, which opens a new way to stop the progression and metastasis of pancreatic cancer by inhibiting the PPAR-delta protein.
November 6, 2025

The 'Metabolism and Tumor Stem Cells' group at IIS Aragón publishes a review in the journal Cells on the role of PPAR receptors in cancer

The article analyzes how peroxisome proliferator-activated receptors (PPARs) influence key properties of tumor stem cells, such as resistance to treatments, the ability to initiate tumors, or evasion of the immune system.
September 11, 2025

Alejandra González, the biologist with the key to curing pancreatic cancer: "It could be applied to more tumors."

The proposal by the scientist from the Aragón Health Research Institute (IIS Aragón) was recognized a few months ago by L'Oréal-UNESCO 'For Women in Science'.
4 July 2025

Researchers at the IIS Aragón have identified a new therapeutic target to prevent metastasis in pancreatic cancer.

The "Metabolism and Tumor Stem Cells" group at the IIS Aragón has demonstrated a novel way to slow the progression and metastasis of this type of cancer in animal models.
26 June, 2025

Scientist Alejandra González's strategy can be applied to several types of cancer to improve survival rates.

The IIS Aragón researcher has recently been recognized with the 2025 L'Oréal-UNESCO 'For Women in Science' award for her unique approach to combating pancreatic cancer.
5 December, 2023

Patricia Sancho: «Spanish researchers are used to squeezing every euro they give us»

Patricia Sancho, researcher at IIS Aragón, on the back page of El Periódico de Aragón to talk about the project in which she collaborates, awarded by Fundación La Caixa with €1.000.000
November 23, 2023

The ”la Caixa” Foundation promotes a project with the participation of the IIS Aragón for the early diagnosis and treatment of pancreatic cancer

Patricia Sancho, researcher at IIS Aragón, collaborates in one of the projects awarded with nearly one million euros to advance the early diagnosis of pancreatic cancer.